Last reviewed · How we verify
Delayed enteral nutrition — Competitive Intelligence Brief
marketed
Critical Care / Nutritional Support
Small molecule
Live · refreshed every 30 min
Target snapshot
Delayed enteral nutrition (Delayed enteral nutrition) — Nanjing University School of Medicine. Delayed enteral nutrition is a nutritional intervention strategy that postpones the initiation of feeding via the gastrointestinal tract following acute illness or injury.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Delayed enteral nutrition TARGET | Delayed enteral nutrition | Nanjing University School of Medicine | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Delayed enteral nutrition CI watch — RSS
- Delayed enteral nutrition CI watch — Atom
- Delayed enteral nutrition CI watch — JSON
- Delayed enteral nutrition alone — RSS
Cite this brief
Drug Landscape (2026). Delayed enteral nutrition — Competitive Intelligence Brief. https://druglandscape.com/ci/delayed-enteral-nutrition. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab